SCHEMBL323629

SCHEMBL323629

O=CC(c1cccs1)N1CCN(c2ncnc3[nH]ccc23)CC2(CC2)C1

nearest known ligand 0.45

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
JAK3 P52333 15/20 0.45
RPS6KB1 P23443 1/20 0.43
JAK2 O60674 6/20 0.43
JAK1 P23458 6/20 0.43
TYK2 P29597 6/20 0.43
AKT2 P31751 3/20 0.41
KIT P10721 2/20 0.41
GSK3B P49841 2/20 0.41
ROCK2 O75116 1/20 0.41
AKT1 P31749 1/20 0.41
AKT3 Q9Y243 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL324666 0.85 JAK3 (0.52) JAK3RPS6KB1JAK2JAK1TYK2
SCHEMBL323030 0.84 JAK3 (0.43) JAK3JAK2JAK1TYK2AKT2
SCHEMBL323269 0.83 AKT2 (0.54) JAK3RPS6KB1JAK2JAK1TYK2
SCHEMBL322722 0.83 AKT1 (0.54) RPS6KB1AKT2KITGSK3BROCK2
SCHEMBL324141 0.82 JAK3 (0.43) JAK3JAK2JAK1TYK2AKT2
SCHEMBL323282 0.82 AKT2 (0.48) JAK3RPS6KB1JAK2JAK1TYK2
SCHEMBL324613 0.82 JAK3 (0.53) JAK3JAK2JAK1TYK2AKT2
SCHEMBL323241 0.82 JAK3 (0.46) JAK3JAK2JAK1TYK2AKT2
SCHEMBL325110 0.82 AKT1 (0.53) JAK3JAK2JAK1TYK2AKT2
SCHEMBL323781 0.82 JAK3 (0.53) JAK3JAK2JAK1TYK2AKT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2590981-A1 NOVEL HOMOPIPERAZINE DERIVATIVES AS PROTEIN TYROSINE KINASE INHIBITORS AND PHARMACEUTICAL USE THEREOF Leo Pharma A/S (DK) 2013-05-15 EP disclosed
WO-2012003829-A1 NOVEL HOMOPIPERAZINE DERIVATIVES AS PROTEIN TYROSINE KINASE INHIBITORS AND PHARMACEUTICAL USE THEREOF LEO PHARMA A/S (DK) 2012-01-12 WO disclosed